Home
News
News archive
Diamond Information


home > news New therapy doubles lung cancer survival time

New therapy doubles lung cancer survival time




Combining an immunotherapy drug with chemotherapy nearly doubled the survival time of some lung cancer patients compared to patients treated with chemotherapy alone, new research published Monday in the New England Journal of Medicine showed.



Click Here to read the entire article...



Find this article in Google